NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 18 filers reported holding NEPHROS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $252,654 | -0.8% | 170,712 | +3.9% | 0.00% | – |
| Q2 2023 | $254,662 | +62.3% | 164,298 | +12.0% | 0.00% | – |
| Q1 2023 | $156,938 | -7.5% | 146,685 | 0.0% | 0.00% | – |
| Q4 2022 | $169,744 | +26.7% | 146,685 | -0.7% | 0.00% | – |
| Q3 2022 | $134,000 | -28.7% | 147,783 | +20.5% | 0.00% | – |
| Q2 2022 | $188,000 | -65.2% | 122,678 | -0.2% | 0.00% | – |
| Q1 2022 | $541,000 | -25.5% | 122,978 | 0.0% | 0.00% | – |
| Q4 2021 | $726,000 | -18.5% | 122,978 | +21.0% | 0.00% | – |
| Q3 2021 | $891,000 | -12.1% | 101,618 | +1.7% | 0.00% | – |
| Q2 2021 | $1,014,000 | +58.4% | 99,936 | +3.9% | 0.00% | – |
| Q1 2021 | $640,000 | +10.7% | 96,195 | +42.6% | 0.00% | – |
| Q4 2020 | $578,000 | +41.0% | 67,439 | +18.9% | 0.00% | – |
| Q3 2020 | $410,000 | -13.9% | 56,737 | 0.0% | 0.00% | – |
| Q2 2020 | $476,000 | +33.3% | 56,737 | 0.0% | 0.00% | – |
| Q1 2020 | $357,000 | – | 56,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEXFORD CAPITAL LP | 3,395,579 | $21,391,000 | 7.91% |
| BARD ASSOCIATES INC | 207,569 | $2,640,000 | 1.94% |
| Parkman Healthcare Partners LLC | 251,366 | $1,584,000 | 0.73% |
| Cowen Prime Services LLC | 154,800 | $975,000 | 0.60% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 12,957 | $82,000 | 0.07% |
| INGALLS & SNYDER LLC | 133,140 | $839,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 39,863 | $251,000 | 0.05% |
| B. Riley Wealth Advisors, Inc. | 14,428 | $91,000 | 0.01% |
| HighTower Advisors, LLC | 43,210 | $273,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 34,249 | $216,000 | 0.00% |